PMN Archived Articles
Probing the Potential of PMN's Precision Therapies: A Deep Dive into the Biotech Innovator
Published on March 15, 2025
ProMIS Neurosciences (NASDAQ:PMN): Pioneering Antibody Therapeutics Targeting Toxic Misfolded Proteins in Neurodegenerative Diseases
Published on November 28, 2024
ProMIS Neurosciences Inc. (NASDAQ:PMN): A Promising Alzheimer's Antibody and a Diversified Pipeline
Published on September 24, 2024